PIL seeks curbs on antibiotics sale without prescription

A Mumbai-based lawyer has filed a public interest litigation (PIL) before the Bombay High Court seeking a directive to restrict over-the-counter sale of antibiotics in India, the world’s “largest consumer of antibiotics”.
The petition followed investigation by an activist who found that antibiotics under ‘restricted use’ were freely available over the counter across pharmacies in India.
The PIL pointed to the United Nations high-level meeting on antimicrobial resistance and said a UN declaration had asked countries to come up with an action plan to curb the misuse of antibiotics by 2018. “That the pressure is on India, the world’s largest consumer of antibiotics and where carelessness in antibiotic use and environmental antibiotic pollution has been documented,” the petition said.
Antibiotic drugs are part of a nearly Rs. 17,000-crore business in India, growing at 5-6% annually. India is one of the biggest consumers of antibiotics. These drugs are also used rampantly in agriculture, specifically for poultry and livestock.
2026-08-19
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Sekisui Specialty Chemicals Has Announced a Global Price Increase
-
German Chemical Industry Output Slumps to Lowest Utilization Rate Since 1991
-
Kemira to Acquire Water Engineering for USD 150 Million
-
Sumitomo Chemical Launches Pilot Plant for Ethanol-to-Propylene Process
-
Honeywell Acquires Johnson Matthey Catalyst Business at a Discount, Cutting £475 Million from the Price
-
End of an Era: KDC/One to Close 150-Year-Old Somerset Cosmetics Factory as Production Shifts to Scotland
-
Echoes of Overcapacity: The Structural Anxiety of China’s EVA Industry Chain
-
The Cold Cycle: PVC Market’s Chill and Faint Light Ahead
-
Minoxidil Safety Under Global Review as Infant Exposure Risks Surface
-
Substandard Drug Findings Expose Deep Structural Gaps in Medicine Quality Control
Recommend Reading
-
ATSP Composite Breakthrough Offers Aerospace Self-Healing and Shape Recovery Published in Top Journals
-
Huayi Group Lists 25 Percent Stake in Edoco China for 320 Million Yuan Signals Major Asset Optimization Push
-
Adnoc L&S Surges 40 Percent in Revenue and Unveils $3 Billion Expansion Plan for 2029
-
EU Plans Broader Quotas and Tariffs on China, With Chemicals Clearly Named
-
Trump’s Steel, Aluminum and Copper Tariff Changes Pull Chemical Manufacturing Into the Impact Zone
-
Premium Global Chemical Sourcing Requests (14-17May, 2026)
-
Your Plant Has the Data. Your AI Cannot Reach It. Here Is Why That Is the Core Problem in Chemical Manufacturing.
-
Insufficient Support, May Butanol Prices in China Decrease by Nearly 10%
-
Lithium Carbonate May Remain in a Volatile Range in June
-
Spread Widens as Shandong Cyclohexanone Market Prices Continue to Decline in May